GSK-2018682
Iinkcukacha zeMveliso
Iithegi zeMveliso
| Ubungakanani bePakethe | Ubukho | Ixabiso (USD) |
Igama leMchiza:
4-(4-(5-(5-chloro-6-isopropoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl)-1H-indol-1-yl)butanoic acid
Ikhowudi yoncumo:
O=C(O)CCCN1C=CC2=C1C=CC=C2C3=NOC(C4=CC(Cl)=C(OC(C)C)N=C4)=N3
Ikhowudi ye-InChi:
InChI=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5-3-6- 18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1-2H3,(H , 28, 29)
Isitshixo se-InChi:
I-FIGDBFIDKDNIG-UHFFFAOYSA-N
Igama elingundoqo:
1034688-30-6;CAS:1034688-30-6;CAS:1034688-30-6;GSK-2018682;GSK 2018682;GSK2018682; 2018682
Ukunyibilika:Inyibilika kwi-DMSO
Ugcino:0 - 4 C kwixesha elifutshane (iintsuku ukuya kwiiveki), okanye -20 C ixesha elide (iinyanga).
Inkcazo:
I-GSK2018682 i-agonist ye-S1P1 kunye ne-S1P5 receptors.
Ithagethi: I-Agonists ye-S1P1 kunye ne-S1P5 yabamkeli



![(S)-2-(4-(4-(4-(5-(1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo[2,1- f][1,2,4]triazin-6-yl)-1H-pyrazol-1-yl)than-1-ol](http://www.caerulumpharm.com/uploads/微信截图_20220802163212-300x280.png)



